Percorrendo por Autor VILLELA, ANNE D.
Mostrando regs. 1 a 6 de 6
Data de publicação | Título | Autor(es) |
2021 | Anti-tubercular profile of new selenium-menadione conjugates against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain and multidrug-resistant clinical isolates | RIBEIRO, RUAN C.B.; DE MARINS, DANIEL B.; DI LEO, IRIS, et al |
2017 | Functional, thermodynamics, structural and biological studies of in silico-identified inhibitors of Mycobacterium tuberculosis enoyl-ACP(CoA) reductase enzyme | MARTINELLI, LEONARDO K. B.; ROTTA, MARIANE; VILLELA, ANNE D., et al |
2017 | Functional, thermodynamics, structural and biological studies of in silico-identified inhibitors of Mycobacterium tuberculosis enoyl-ACP(CoA) reductase enzyme | MARTINELLI, LEONARDO K. B.; ROTTA, MARIANE; VILLELA, ANNE D., et al |
2018 | Is IQG-607 a Potential Metallodrug or Metallopro-Drug With a Defined Molecular Target in Mycobacterium tuberculosis? | ABBADI, BRUNO L.; RODRIGUES-JUNIOR, VALNÊS DA SILVA; DADDA, ADILIO DA SILVA, et al |
2020 | Nonclinical evaluation of IQG-607, an anti-tuberculosis candidate with potential use in combination drug therapy | RODRIGUES-JUNIOR, VALNÊS S.; VILLELA, ANNE D.; ABBADI, BRUNO L., et al |
2018 | Pre-clinical evaluation of quinoxaline-derived chalcones in tuberculosis | MURADÁS, THAÍS C.; ABBADI, BRUNO L.; VILLELA, ANNE D., et al |